Insider Selling: Oscar Health (NYSE:OSCR) Director Sells 34,120 Shares of Stock

Oscar Health, Inc. (NYSE:OSCR) Director Mario Schlosser sold 34,120 shares of the business’s stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total value of $748,592.80. Following the sale, the director owned 480,866 shares in the company, valued at approximately $10,550,200.04. The trade was a 6.63% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Stock Performance

Oscar Health stock traded up $3.04 during trading hours on Thursday, hitting $23.54. 10,532,228 shares of the stock traded hands, compared to its average volume of 7,845,401. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.11 and a quick ratio of 1.11. The firm’s 50 day moving average price is $17.92 and its 200-day moving average price is $15.93. The stock has a market capitalization of $7.10 billion, a price-to-earnings ratio of -39.90, a P/E/G ratio of 1.48 and a beta of 2.37. Oscar Health, Inc. has a 1 year low of $10.69 and a 1 year high of $25.58.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $2.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.96. The business had revenue of $4.65 billion during the quarter, compared to analysts’ expectations of $4.90 billion. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The company’s revenue for the quarter was up 52.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.92 EPS. As a group, equities analysts expect that Oscar Health, Inc. will post 0.47 EPS for the current fiscal year.

Hedge Funds Weigh In On Oscar Health

Large investors have recently bought and sold shares of the business. Vanguard Group Inc. raised its holdings in Oscar Health by 2.7% in the 4th quarter. Vanguard Group Inc. now owns 20,701,250 shares of the company’s stock worth $297,477,000 after purchasing an additional 540,851 shares during the period. State of Michigan Retirement System acquired a new position in Oscar Health in the 3rd quarter worth about $27,448,000. Universal Beteiligungs und Servicegesellschaft mbH raised its holdings in Oscar Health by 1,097.8% in the 4th quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 237,882 shares of the company’s stock worth $3,418,000 after purchasing an additional 218,022 shares during the period. Farallon Capital Management LLC raised its holdings in shares of Oscar Health by 146.5% during the third quarter. Farallon Capital Management LLC now owns 3,639,000 shares of the company’s stock valued at $68,886,000 after acquiring an additional 2,163,000 shares during the last quarter. Finally, Fred Alger Management LLC raised its holdings in shares of Oscar Health by 225.6% during the third quarter. Fred Alger Management LLC now owns 1,212,383 shares of the company’s stock valued at $22,950,000 after acquiring an additional 840,038 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently issued reports on OSCR. UBS Group boosted their price objective on Oscar Health from $15.00 to $20.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Wells Fargo & Company set a $20.00 price objective on Oscar Health and gave the company an “equal weight” rating in a report on Thursday. Weiss Ratings reissued a “sell (d)” rating on shares of Oscar Health in a report on Tuesday, April 21st. Raymond James Financial raised Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 price objective for the company in a report on Thursday, February 12th. Finally, Wolfe Research assumed coverage on Oscar Health in a report on Tuesday, May 5th. They issued a “peer perform” rating for the company. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $20.22.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.